AD educational videos for Atopic Dermatitis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
BMC Pediatric Dermatology Clinics, Boston, MAAtopic DermatitisAD educational videos - Other
Eligibility
< 18
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether videos are a more effective method of patient education than paper handouts, based on clinical outcomes like the severity of atopic dermatitis, how much it affects sleep, and how much itchiness it causes.

Eligible Conditions
  • Atopic Dermatitis

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

4 Primary · 5 Secondary · Reporting Duration: 6 months

6 months
Atopic Dermatitis related costs
Month 2
Change in eczema severity based on the Eczema Area and Severity Index (EASI)
Change in eczema severity based on the Patient Oriented Eczema Measure (POEM)
Change in knowledge of coping with Atopic Dermatitis (AD)
Change in patient/parent confidence
Change in sleep quality
Change in the overall quality of life
Change in the severity of itch
up to 2 months
Satisfaction with therapeutic patient education (TPE)

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Group 1- Printed educational materials
1 of 2
Group 2- Educational videos
1 of 2

Active Control

Experimental Treatment

560 Total Participants · 2 Treatment Groups

Primary Treatment: AD educational videos · No Placebo Group · N/A

Group 2- Educational videos
Other
Experimental Group · 1 Intervention: AD educational videos · Intervention Types: Other
Group 1- Printed educational materials
Other
ActiveComparator Group · 1 Intervention: AD printed educational materials · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months

Who is running the clinical trial?

Boston UniversityLead Sponsor
425 Previous Clinical Trials
10,042,388 Total Patients Enrolled
Margaret Lee, MD PhDPrincipal InvestigatorBoston University

Eligibility Criteria

Age < 18 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You can connect to the internet.
You must be able to speak Spanish or English.

Frequently Asked Questions

Is the recruitment phase of this research endeavor still open?

"The information available on clinicaltrials.gov indicates that the trial is still open for patient recruitment and has been since December 1st, 2022. The project seeks to find 560 participants from a single research site." - Anonymous Online Contributor

Unverified Answer

How extensive is the sample size of this research?

"Affirmative, according to clinicaltrials.gov details, this trial is recruiting participants at the present time and was initially posted on December 1st 2022 with its most recent update taking place a month later. 560 people need to be recruited from one single centre for this study." - Anonymous Online Contributor

Unverified Answer

What are the desired outcomes from this clinical research?

"This trial seeks to evaluate the efficacy of a therapeutic intervention through assessing changes in eczema severity, as measured by the Eczema Area and Severity Index (EASI), over a two-month period. Secondary objectives include evaluating participant/parental confidence, knowledge of coping with atopic dermatitis based on an investigator developed survey, and satisfaction with therapeutic patient education via another investigator developed questionnaire." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.